Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCl) is an essential electrolyte used to prevent or treat hypokalemia. It is available in oral and intravenous (IV) formulations.
## Primary Indications
* Prevention and treatment of hypokalemia.
* Potassium replacement in patients with or at risk for hypokalemia (e.g., diuretic use, vomiting, diarrhea, certain gastrointestinal disorders).
## Adult Dosing
* **Prevention of hypokalemia:** 20 mEq (1.5 g) daily, divided into 1-2 doses.
* **Treatment of hypokalemia:**
* Mild to moderate hypokalemia (serum K+ 3.0-3.5 mEq/L): 40-100 mEq (3-7.5 g) daily, divided into 2-4 doses.
* Severe hypokalemia (serum K+ <3.0 mEq/L): Dosing depends on severity and patient condition. Often initiated with IV administration. Oral doses can range from 10-20 mEq (0.75-1.5 g) per dose, not to exceed 20 mEq (1.5 g) per dose or 100 mEq (7.5 g) per day without continuous ECG monitoring.
* **IV administration:** Dosing varies significantly based on serum potassium levels and cardiac monitoring availability.
* *General replacement:* Typically 20-40 mEq (1.5-3 g) added to 1 Liter of IV fluid per 24 hours.
* *Severe hypokalemia (serum K+ <2.5 mEq/L) with ECG changes:* May require up to 40 mEq/hour, administered via a central line with continuous cardiac monitoring. **Maximum infusion rate typically should not exceed 10-20 mEq/hour (unless in a critical care setting with continuous ECG monitoring, where rates up to 40 mEq/hour may be used).**
* **Maximum single dose (IV):** Generally limited to 40 mEq (3 g) per infusion bag, with a maximum of 3 bags (120 mEq) in 24 hours, especially if infused peripherally. Central line administration for higher doses is preferred.
## Pediatric Dosing
* **Maintenance:** 1-2 mEq/kg/day, not to exceed adult maximums.
* **Correction:** Dosing is highly individualized based on serum potassium, clinical status, and age. Oral doses typically range from 0.5-2 mEq/kg/day divided into multiple doses. IV doses are administered with extreme caution and close monitoring.
* **IV infusion rates:** Generally limited to 0.5-1 mEq/kg/hour, not to exceed 20 mEq/hour, with continuous cardiac monitoring.
## Dose Adjustments
* **Renal impairment:** Dose reduction is necessary. Monitor potassium levels closely. In severe renal impairment, potassium supplementation may be contraindicated.
* **Adrenal insufficiency:** Patients may be more sensitive to potassium effects.
## Contraindications
* Hyperkalemia.
* Conditions that predispose to hyperkalemia, such as severe renal impairment, untreated Addison's disease, crush syndrome, severe burns, and certain cardiac conditions (e.g., complete heart block without a pacemaker).
* Known hypersensitivity to potassium chloride.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, diarrhea, abdominal discomfort, gastrointestinal bleeding (especially with sustained-release formulations).
* **Cardiovascular:** Arrhythmias, cardiac arrest (with rapid IV infusion or hyperkalemia).
* **Other:** Hyperkalemia, hyperchloremic acidosis.
## Key Drug Interactions
* **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia.
* **ACE inhibitors and ARBs:** Increased risk of hyperkalemia.
* **NSAIDs:** May reduce the kaliuretic effect of potassium, increasing risk of hyperkalemia.
* **Heparin:** Can impair potassium excretion and increase the risk of hyperkalemia.
* **Digoxin:** Hypokalemia enhances digoxin toxicity; conversely, hyperkalemia reduces digoxin's therapeutic effect.
## Monitoring
* Serum potassium levels (frequent monitoring, especially during IV administration and dose adjustments).
* Renal function (BUN, creatinine).
* ECG (especially with rapid IV infusion, severe hypokalemia, or risk factors for cardiac arrhythmias).
* Signs and symptoms of hypokalemia and hyperkalemia.
## Clinical Pearls
* Oral potassium chloride should be taken with meals or after food to minimize gastrointestinal upset.
* Dilute oral liquid potassium chloride in a sufficient amount of fluid (e.g., 4-8 ounces) to improve palatability and reduce esophageal irritation.
* IV potassium chloride must be diluted and administered slowly. **Never administer IV potassium chloride as an undiluted IV push.**
* Sustained-release formulations may reduce GI side effects but can still cause irritation or obstruction.
* Rapid IV administration of potassium is dangerous and can be fatal.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and local protocols for definitive guidance.*